Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Renunda Hicks"'
Autor:
Peifeng Chen, Anita Arthur, Kaitlyn M. Morabito, Kristin Leach, Xiaolin Wang, Grace L. Chen, Attila Nagy, Lauren A. Chang, Jon Cooper, Amy L. Chamberlain, Janel Holland-Linn, Olga Vasilenko, Alicia T. Widge, Shufeng Bai, Judith A Stein, LaSonji A. Holman, Cristina Carter, Iris Pittman, Deepika Gollapudi, Lisa A. Kueltzo, Colleen Fridley, Michelle C. Crank, Amritha Menon, William Whalen, Mridul Ghosh, Cynthia S. Hendel, Martha Nason, Amy Liu, Althaf Hussain, Laura Novik, Pernell Williams, Maria Burgos Florez, Robert T. Bailer, Thuy Nguyen, Brenda Larkin, Tracy J. Ruckwardt, Pamela Costner, Lam Le, Zhong Zhao, Elizabeth Carey, Vera Ivleva, Jennifer Walters, John R. Mascola, Jennifer Cunningham, Olga Trofymenko, Ya-chen Chang, Somia P. Hickman, Martin R. Gaudinski, Richard M. Schwartz, Slobodanka D. Manceva, Kevin Carlton, Barney S. Graham, Rahul Ragunathan, Jason G. D. Gall, Ana M. Ortega-Villa, Colin Tran, Sarah H. Plummer, Abidemi Ola, Ro Shauna S Rothwell, Ingelise J. Gordon, Mingzhong Chen, Jamie G. Saunders, Aba Mensima Eshun, Bob C. Lin, Azad Kumar, Nina M. Berkowitz, Xun Liu, Cora Trelles Cartagena, Emily Phung, Galina Yamshchikov, Joe Horwitz, Sarah O’Connell, Florence Kaltovich, Floreliz Mendoza, LaShawn Requilman, Man Chen, Preeti Apte, Christopher Lee, Renunda Hicks
Publikováno v:
Lancet Respir Med
Multiple active vaccination approaches have proven ineffective in reducing the substantial morbidity and mortality caused by respiratory syncytial virus (RSV) in infants and older adults (aged ≥65 years). A vaccine conferring a substantial and sust
Autor:
Martin R, Gaudinski, Nina M, Berkowitz, Azza H, Idris, Emily E, Coates, LaSonji A, Holman, Floreliz, Mendoza, Ingelise J, Gordon, Sarah H, Plummer, Olga, Trofymenko, Zonghui, Hu, Andrezza, Campos Chagas, Sarah, O'Connell, Manjula, Basappa, Naomi, Douek, Sandeep R, Narpala, Christopher R, Barry, Alicia T, Widge, Renunda, Hicks, Seemal F, Awan, Richard L, Wu, Somia, Hickman, Diane, Wycuff, Judy A, Stein, Christopher, Case, Brian P, Evans, Kevin, Carlton, Jason G, Gall, Sandra, Vazquez, Britta, Flach, Grace L, Chen, Joseph R, Francica, Barbara J, Flynn, Neville K, Kisalu, Edmund V, Capparelli, Adrian, McDermott, John R, Mascola, Julie E, Ledgerwood, Robert A, Seder
Publikováno v:
The New England journal of medicine. 385(9)
Additional interventions are needed to reduce the morbidity and mortality caused by malaria.We conducted a two-part, phase 1 clinical trial to assess the safety and pharmacokinetics of CIS43LS, an antimalarial monoclonal antibody with an extended hal
Autor:
Robert T. Bailer, Maria Burgos Florez, Lucio Gama, Sung-Youl Ko, Zonghui Hu, Cynthia S. Hendel, Ro Shauna S Rothwell, Amarendra Pegu, Lily Zhang, Brenda Larkin, Katherine V. Houser, Jennifer Cunningham, Martin R. Gaudinski, Olga Vasilenko, Sandra Sitar, Julie E. Ledgerwood, Nicole A. Doria-Rose, Kathy Zephir, Preeti Apte, KC Cheng, William Whalen, Renunda Hicks, Richard A. Koup, Margarita M. Gomez Lorenzo, Floreliz Mendoza, Xiaolin Wang, Cristina Carter, LaSonji A. Holman, Young Do Kwon, Frank J. Arnold, Hope DeCederfelt, Grace L. Chen, Aryan M. Namboodiri, Peter D. Kwong, Kevin Carlton, Adrian B. McDermott, Joseph P. Casazza, Bob C. Lin, Nina M. Berkowitz, Nilusha Jayasinghe, Laura Novik, Catina R. Boyd, Edmund V. Capparelli, Carol Levinson, Galina Yamshchikov, Cora Trelles Cartagena, Carolyn M. Laurencot, Jason G. D. Gall, Michelle Conan-Cibotti, Sarah H. Plummer, Yunda Huang, Abidemi Ola, Pamela Costner, Ingelise J. Gordon, Janardan P. Pandey, Richard M. Schwartz, Judy Stein, Pernell Williams, Florence Kaltovich, Jamie G. Saunders, Iris Pittman, Milalynn Victorino, John R. Mascola, Barney S. Graham
Publikováno v:
The lancet. HIV. 6(10)
Summary Background Human monoclonal antibodies that potently and broadly neutralise HIV-1 are under development to prevent and treat HIV-1 infection. In this phase 1 clinical trial we aimed to determine the safety, tolerability, and pharmacokinetic p
Autor:
Martin R Gaudinski, Katherine V Houser, Kaitlyn M Morabito, Zonghui Hu, Galina Yamshchikov, Ro Shauna Rothwell, Nina Berkowitz, Floreliz Mendoza, Jamie G Saunders, Laura Novik, Cynthia S Hendel, LaSonji A Holman, Ingelise J Gordon, Josephine H Cox, Srilatha Edupuganti, Monica A McArthur, Nadine G Rouphael, Kirsten E Lyke, Ginny E Cummings, Sandra Sitar, Robert T Bailer, Bryant M Foreman, Katherine Burgomaster, Rebecca S Pelc, David N Gordon, Christina R DeMaso, Kimberly A Dowd, Carolyn Laurencot, Richard M Schwartz, John R Mascola, Barney S Graham, Theodore C Pierson, Julie E Ledgerwood, Grace L Chen, Sarah Plummer, Pamela Costner, Kathryn Zephir, Joseph Casazza, Abidemi Ola, Milalynn Victorino, Carol Levinson, William Whalen, Xiaolin Wang, Jennifer Cunningham, Olga Vasilenko, Maria Burgos Florez, Somia Hickman, Iris Pittman, Lam Le, Brenda Larkin, Charla Andrews, Preeti Apte, Renunda Hicks, Cora Trelles Cartagena, Pernell Williams, Catina R Boyd, Michelle Conan-Cibotti, Judy Stein, Florence Kaltovich, Hope DeCederfelt, Stacey McAdams, Phyllis Renehan, Wilbur Chen, Nancy Greenberg, Nancy Wymer, Linda Wadsworth, Melissa Billington, Toni Robinson, Colleen Boyce, Faith Pa'ahana Brown, Lisa Chrisley, Alyson Kwon, Prashant Patel, Panagoita Kominou, Brenda Dorsey, Staci Eddington, Shinyi Telscher, Myoughee Lee, Regina Mosely, April Ross, Geoffrey Ford, Briyana Domjahn, Jianguo Xu, Allison Beck, Rebecca Fineman, Shiela Heeke, Jean Winter, Shashi Nagar, Colleen Kelley, Mark Mulligan
Publikováno v:
The Lancet
Summary Background The Zika virus epidemic and associated congenital infections have prompted rapid vaccine development. We assessed two new DNA vaccines expressing premembrane and envelope Zika virus structural proteins. Methods We did two phase 1,